Delivery Order SPE2DB20D1100-SPE2DB25FA8M4

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,436.25, is for the delivery of Wegovy 1 mg/0.5 ml pens. It is a firm fixed-price delivery order contract with a completion date of February 7, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,025.14, is for the delivery of Wegovy 2.4 mg/0.75 ml Pen 0.75 ml, a specialty medication. The contract has a firm fixed price and an ultimate completion date of November 28, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $5,551.64 and is for the pharmaceutical product Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract is a firm fixed price agreement with a completion date of December 19, 2023. AmerisourceBergen Drug Corp is the prime contractor, and this award is part of a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,251.41, is a delivery order for the medication Wegovy 0.5 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price contract with a completion date of February 13, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.00, is for the delivery of the prescription drug Wegovy 2.4 mg/0.75 ml pen with a 0.75 ml capacity. The contract is a Firm Fixed Price Delivery Order with a completion date of February 18, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.00, is for the delivery of the drug Wegovy 0.5 mg/0.5 ml pen in 0.5 ml quantities. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 31, 2024. The contract does not have a set-aside designation, indicating open competition. In addition to this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,675.08, is for the delivery of Wegovy 2.4 mg/0.75 ml pens. It is a firm fixed-price delivery order contract with a completion date of March 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,228.50, is for the delivery of Wegovy 2.4 mg/0.75 ml pen 0.75 ml, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,291.24 firm fixed-price delivery order contract is for the supply of the prescription drug Wegovy 0.25 mg/0.5 ml pen (0.5 ml). The contract has an ultimate completion date of April 25, 2023. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,572.66, is for the delivery of Wegovy 1 mg/0.5 mL pens. It is a firm-fixed-price delivery order contract with a completion date of January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA8M4
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,276.00, is for the delivery of the medication Wegovy 2.4 mg/0.75 ml pen. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/30/25, 9:50 AM